Linezolid minimum inhibitory concentration (MIC) creep in methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates at a single Japanese center.

MLA

Miyazaki, Motoyasu, et al. “Linezolid Minimum Inhibitory Concentration (MIC) Creep in Methicillin-Resistant Staphylococcus Aureus (MRSA) Clinical Isolates at a Single Japanese Center.” Biological & Pharmaceutical Bulletin, vol. 37, no. 4, 2014, pp. 679–82. EBSCOhost, https://doi.org/10.1248/bpb.b13-00670.

APA

Miyazaki, M., Nagata, N., Miyazaki, H., Matsuo, K., Takata, T., Tanihara, S., & Kamimura, H. (2014). Linezolid minimum inhibitory concentration (MIC) creep in methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates at a single Japanese center. Biological & Pharmaceutical Bulletin, 37(4), 679–682. https://doi.org/10.1248/bpb.b13-00670

Chicago

Miyazaki, Motoyasu, Nobuhiko Nagata, Hiroyuki Miyazaki, Koichi Matsuo, Tohru Takata, Shinichi Tanihara, and Hidetoshi Kamimura. 2014. “Linezolid Minimum Inhibitory Concentration (MIC) Creep in Methicillin-Resistant Staphylococcus Aureus (MRSA) Clinical Isolates at a Single Japanese Center.” Biological & Pharmaceutical Bulletin 37 (4): 679–82. doi:10.1248/bpb.b13-00670.